Categories: News

Functional Brands Inc. to Participate at the Sidoti Year End Virtual Investor Conference

Lake Oswego, Oregon–(Newsfile Corp. – December 8, 2025) – Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced that Eric Gripentrog, Chief Executive Officer & Director and David R. Wells, Financial Counsel will participate in the Sidoti Year End Virtual Investor Conference, to be held December 10-11, 2025.

Mr. Gripentrog and Mr. Wells will meet virtually with investors and present at approximately 3:15 p.m. Eastern Time on Wednesday, December 10, 2025. A live webcast of their presentation will be accessible on the Company’s Investor Relations website at https://www.functionalbrandsinc.com/investors/ or directly here.

About Functional Brands Inc.
Functional Brands Inc. is a health and wellness company focused on acquiring and growing science-based consumer brands. With a portfolio that includes trusted names like Kirkman®, P2i by Kirkman®,Healthy Assist by Kirkman; Functional Brands is committed to providing high-quality, effective solutions that support healthier lives.

For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com.

Investor Relations Contact:
FunctionalBrands@icrinc.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277193

Staff

Recent Posts

rYojbaba Subsidiary Sakai Seikotsuin Serves as an Official Trainer at the 2025 Taipei Wake Open

FUKUOKA, Japan, Dec. 08, 2025 (GLOBE NEWSWIRE) -- rYojbaba Co., Ltd. (Nasdaq: RYOJ) ("rYojbaba" or…

1 second ago

IRADIMED Announces Special Cash Dividend of $0.50 Per Share

ORLANDO, Fla., Dec. 08, 2025 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), announced…

3 seconds ago

SS Innovations Submits 510(k) Premarket Notification to the FDA for the Company’s SSi Mantra Surgical Robotic System

-- Submission covers multiple indications including general, urological, colorectal, gynecological and cardiac surgeries -- FORT…

7 seconds ago

CytoDyn to Showcase PD-L1 Upregulation and Improved Survival in Metastatic Triple Negative Breast Cancer at the San Antonio Breast Cancer Symposium

Leronlimab treatment is associated with upregulation of PD-L1 in circulating tumor cells and cancer-associated macrophage-like…

14 seconds ago